LexaGene Holdings Inc. (CVE:LXG – Get Free Report) fell 19.2% during trading on Tuesday . The stock traded as low as C$0.10 and last traded at C$0.11. 2,135,377 shares changed hands during mid-day trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Price Performance
The company has a current ratio of 1.39, a quick ratio of 1.13 and a debt-to-equity ratio of 138.01. The company has a market capitalization of C$14.77 million, a P/E ratio of -1.31 and a beta of 2.26. The firm has a fifty day moving average of C$0.11 and a 200 day moving average of C$0.11.
LexaGene Company Profile
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Featured Articles
- Five stocks we like better than LexaGene
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Comparing and Trading High PE Ratio Stocks
- Lockheed Martin Stock Aims for a Fresh All-Time High
- What Investors Need to Know to Beat the Market
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
